1. Raviglione M., Marais B., Floyd K.. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 379(9829):2012 May 19;1902-1912.
2. Jam S., Sabzvar D., Seyed Alinaghi S.. Frequency of Mycobacterium tuberculosis infection among Iranian patients with HIV/AIDS by PPD test. Acta Med Iran 48(1):2001;67-71.
3. World Health Organization (WHO) . WHO report: global tuberculosis control: epidemiology, strategy, financing. 2013. WHO; Geneva (Switzerland): Tech. Rep. WHO/HTM/TB/2009:411.
5. Zhao P., Li X.J., Zhang S.F.. Social behavior risk factors for drug resistant tuberculosis in mainland China: a meta-analysis. J Int Med Res 40:2012;436-445.
6. Van der Werf M.J., Langendam M.W., Huitric E.. Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis. Eur Respir J 39(6):2012 Jun;1511-1519.
7. World Health Organization (WHO) . Global tuberculosis report 2012. 2012. WHO; Geneva (Switzerland): pp 105,
8. Mozafari M., Farnia P., Afraei M.. Molecular diversity of
Mycobacterium tuberculosis strains in different provinces of Iran. Iran J Microbiol 5(4):2013;366-373.
9. Dinnes J., Deeks J., Kunst H.. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 11(3):2007;1-196.
10. Migliori G.B., Centis R., Lange Richardson M.. Emerging epidemic of drug resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives. Curr Opin Pulm Med 16(3):2010 May;171-179.
11. Petroff S.. A new and rapid method for the isolation and cultivation of tubercle bacilli directly from the sputum and feces. J Exp Med 21(1):1915 Jan;38-42.
12. Brooks G.F., Carroll K.C., Butel J.S.. Jawetz, Melnick, & Adelberg's Medical Microbiology. 26th ed. 2013. McGraw-Hill; New York: pp 324-325.
13. Rieder H.L., Chonde T.M., Myking H.. The Public Health Service National Tuberculosis Reference Laboratory and the National Laboratory Network International Union against Tuberculosis and Lung Disease. 1998. pp 68-72.
14. World Health Organization (WHO) . Treatment of tuberculosis. Guidelines for National TB Programs. 3rd ed. 2003. WHO; Geneva (Switzerland): pp 29-42; Report No.: 2003WHO/CDS/TB/2003.313.
15. World Health Organization (WHO) . Guidelines for the programmatic management of drug resistance tuberculosis. 2006. WHO; Geneva (Switzerland): pp 6-8; Report No.: WHO/HTM/TB/2006.361.
16. Khosravi A.D., Dezfulian A., Alavi S.M.. Detection of isoniazid and rifampin resistant Mycobacterium tuberculosis isolated from tuberculosis patients using conventional method and PCR. Pak J Med Sci 22(1):2006;47-50.
17. Marjani M., Baghaei P., Tabarsi P.. Drug resistance pattern and outcome of treatment in recurrent episodes of tuberculosis. EMHJ 18(9):2012;957-961.
18. World Health Organisation (WHO) . Global health observatory data repository 2011. 2011. WHO; Geneva (Switzerland): pp 39,
19. Alavi S.M., Salami N.. The causes of death among patients with tuberculosis in Khuzestan, Iran. Pak J Med Sci 24(2):2008;217-220.
20. Alavi S.M., Sefidgaran G.H.. Tuberculin survey among school-aged children in Ahvaz, Iran, 2006. Int J Infect Dis 12(4):2008 Jul;406-409.
21. Nasiri M.J., Rezaei F., Zamani S.. Drug resistance pattern of
Mycobacterium tuberculosis isolates from patients of five provinces of Iran. Asian Pac J Trop Med 7(3):2014 Mar;193-196.
22. Metanat M., Shahreki S.H., Sharifi-Mood B.. Prevalence multi drug resistance among pulmonary tuberculosis patients who referred to Boo-Ali hospital. 18th Congress of infectious diseases and tropical medicine: Zahedan (Iran). 2009.
23. Hadizadeh Tasbiti A.R., Yari S.H., Karimi A.. Survey of extensively drug-resistant tuberculosis (XDR-TB) in Iran-Tehran: a retrospective study. African J Microbiol Res 5(22):2011;3795-3800.